http://www.bgandg.com/mms.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) in obtaining the Health Assessment Advisory Service ("HAAS") contract, MAXIMUS set an unattainable target number of healthcare professionals to recruit and an unattainable target number of assessments; (2) throughout the HAAS contract, MAXIMUS was struggling to recruit, train, and ramp-up new health care staff to perform the assessments; (3) the inability to meet its target number of healthcare recruits and target number of assessments meant MAXIMUS would not earn the performance-based incentive fees from the HAAS contract; and (4) consequently, defendants' statements about MAXIMUS, its financial condition, and the outlook for its business, including statements about the HAAS contract and the amount of revenue MAXIMUS expected the contract to contribute, lacked a reasonable basis when made.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: http://www.bgandg.com/mms, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Maximus, you have until October 6, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

If you have held Maximus shares continuously before October 30, 2014, as a long-term shareholder, you may have standing to hold Maximus accountable from the damage the officers and directors may have caused by making them personally responsible. You may also be able to assist in reforming the Company's corporate governance to prevent future wrongdoing.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 473311

"/> SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against MAXIMUS, Inc. (MMS) and Lead Plaintiff Deadline – October 6, 2017 « MarketersMedia – Press Release Distribution Services – News Release Distribution Services
MarketersMEDIA Year End Sale is Finally Back! Get up to 70% OFF on your press releases. Hurry! Limited time only.
Click Here

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against MAXIMUS, Inc. (MMS) and Lead Plaintiff Deadline – October 6, 2017

NEW YORK, NY / ACCESSWIRE / September 13, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against MAXIMUS, Inc. ("Maximus" or the "Company") (NYSE: MMS) and certain of its officers, on behalf of shareholders who purchased Maximus securities between October 30, 2014 through February 3, 2016, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: http://www.bgandg.com/mms.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) in obtaining the Health Assessment Advisory Service ("HAAS") contract, MAXIMUS set an unattainable target number of healthcare professionals to recruit and an unattainable target number of assessments; (2) throughout the HAAS contract, MAXIMUS was struggling to recruit, train, and ramp-up new health care staff to perform the assessments; (3) the inability to meet its target number of healthcare recruits and target number of assessments meant MAXIMUS would not earn the performance-based incentive fees from the HAAS contract; and (4) consequently, defendants' statements about MAXIMUS, its financial condition, and the outlook for its business, including statements about the HAAS contract and the amount of revenue MAXIMUS expected the contract to contribute, lacked a reasonable basis when made.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: http://www.bgandg.com/mms, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Maximus, you have until October 6, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

If you have held Maximus shares continuously before October 30, 2014, as a long-term shareholder, you may have standing to hold Maximus accountable from the damage the officers and directors may have caused by making them personally responsible. You may also be able to assist in reforming the Company's corporate governance to prevent future wrongdoing.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 473311

NEW YORK, NY / ACCESSWIRE / September 13, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against MAXIMUS, Inc. ("Maximus" or the "Company") (NYSE: MMS) and certain of its officers, on behalf of shareholders who purchased Maximus securities between October 30, 2014 through February 3, 2016, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: http://www.bgandg.com/mms.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) in obtaining the Health Assessment Advisory Service ("HAAS") contract, MAXIMUS set an unattainable target number of healthcare professionals to recruit and an unattainable target number of assessments; (2) throughout the HAAS contract, MAXIMUS was struggling to recruit, train, and ramp-up new health care staff to perform the assessments; (3) the inability to meet its target number of healthcare recruits and target number of assessments meant MAXIMUS would not earn the performance-based incentive fees from the HAAS contract; and (4) consequently, defendants' statements about MAXIMUS, its financial condition, and the outlook for its business, including statements about the HAAS contract and the amount of revenue MAXIMUS expected the contract to contribute, lacked a reasonable basis when made.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: http://www.bgandg.com/mms, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Maximus, you have until October 6, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

If you have held Maximus shares continuously before October 30, 2014, as a long-term shareholder, you may have standing to hold Maximus accountable from the damage the officers and directors may have caused by making them personally responsible. You may also be able to assist in reforming the Company's corporate governance to prevent future wrongdoing.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 473311

Source URL: https://marketersmedia.com/shareholder-alert-bronstein-gewirtz-grossman-llc-reminds-investors-of-class-action-against-maximus-inc-mms-and-lead-plaintiff-deadline-october-6-2017-2/238952

Source: AccessWire

Release ID: 238952


Latest News